Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1663: 166-173, 2017 05 15.
Article in English | MEDLINE | ID: mdl-28288870

ABSTRACT

Transient ischemic attack (TIA) has received only little attention in the experimental research field. Recently, we introduced a TIA model for mice, and here we set similar principles for simulating this human condition in Wistar rats. In the model: 1) transient nature of the event is ensured, and 2) 24h after the event animals are free from any sensorimotor deficit and from any detectable lesion by magnetic resonance imaging (MRI). Animals experienced varying durations of ischemia (5, 10, 12.5, 15, 25, and 30min, n=6-8pergroup) by intraluminal middle cerebral artery occlusion (MCAO). Ischemia severity and reperfusion rates were controlled by cerebral blood flow measurements. Sensorimotor neurological evaluations and MRI at 24h differentiated between TIA and ischemic stroke. Hematoxylin and eosin staining and apoptotic cell counts revealed pathological correlates of the event. We found that already 12.5min of ischemia was long enough to induce ischemic stroke in Wistar rats. Ten min or shorter durations induced neither gross neurological deficits nor infarcts visible on MRI, but histologically caused selective neuronal necrosis. A separate group of animals with 10min of ischemia followed up to 1week after reperfusion remained free of infarction and any MRI signal change. Thus, 10min or shorter focal cerebral ischemia induced by intraluminal MCAO in Wistar rats provides a clinically relevant TIA the rat. This model is useful for studying molecular correlates of TIA.


Subject(s)
Brain Ischemia/pathology , Disease Models, Animal , Ischemic Attack, Transient/pathology , Animals , Apoptosis , Cerebrovascular Circulation/physiology , Infarction, Middle Cerebral Artery/complications , Ischemic Attack, Transient/veterinary , Male , Necrosis/pathology , Neurons/pathology , Rats , Rats, Wistar , Reperfusion/methods , Stroke/pathology , Time Factors
2.
Neuroscience ; 153(1): 175-81, 2008 Apr 22.
Article in English | MEDLINE | ID: mdl-18367342

ABSTRACT

The blood-brain barrier (BBB) is the principal regulator of blood-borne substance entry into the brain parenchyma. Therefore, BBB leakage, which leads to cerebral edema and influx of toxic substances, is common in pathological conditions such as cerebral ischemia, inflammation, trauma, and tumors. The leakage of BBB after ischemia-reperfusion injury has long been considered to be biphasic, although a considerable amount of discrepancies as for the timing of the second opening does exist among the studies. This led us to evaluate systematically and quantitatively the dynamics of BBB leakage in a rat model of 90-min ischemia-reperfusion, using gadolinium-enhanced (small molecule) magnetic resonance imaging and fluorescent dye Evans Blue (large molecule). BBB leakage was assessed at the following time points after reperfusion: 25 min, 2, 4, 6, 12, 18, 24, 36, 48, and 72 h, and 1, 2, 3, 4, and 5 weeks. We observed BBB leakage for both gadolinium and Evans Blue as early as 25 min after reperfusion. Thereafter, BBB remained open for up to 3 weeks for Evans Blue and up to 5 weeks for gadolinium. Our results show that BBB leakage after ischemia-reperfusion injury in the rat is continuous and long-lasting, without any closure up to several weeks. This is the first systematic and extensive study fully demonstrating BBB leakage dynamics following transient brain ischemia and the findings are of major clinical and experimental interest.


Subject(s)
Blood-Brain Barrier/physiopathology , Brain Edema/physiopathology , Brain Ischemia/physiopathology , Reperfusion Injury/physiopathology , Animals , Blood-Brain Barrier/pathology , Brain Edema/etiology , Brain Edema/pathology , Brain Ischemia/complications , Brain Ischemia/pathology , Cerebral Arteries/physiopathology , Cerebrovascular Circulation/physiology , Coloring Agents/pharmacokinetics , Disease Models, Animal , Evans Blue/pharmacokinetics , Gadolinium/pharmacokinetics , Magnetic Resonance Imaging , Male , Rats , Rats, Wistar , Reperfusion Injury/complications , Reperfusion Injury/pathology , Time Factors
3.
Mol Cell Endocrinol ; 184(1-2): 33-9, 2001 Nov 26.
Article in English | MEDLINE | ID: mdl-11694339

ABSTRACT

Two related ligands, glial cell line-derived neurotrophic factor (GDNF) and neurturin (NRTN), are expressed by Sertoli cells, but their cognate ligand-binding co-receptors, GDNF family receptor alpha1 and alpha2, are displayed by different germ cells suggesting different targets for the ligands. GDNF regulates cell fate decision of undifferentiated spermatogonia 'Science 287 (2000) 1489'. The role of NRTN was now approached by targeted overexpression in mouse testis. Between 3 and 5 weeks of age, transient degeneration of spermatogenic cells was observed in approximately 20% of all five transgenic lines generated. Spermatids and pachytene spermatocytes underwent segmental degeneration, if the rete testis was undilated. When it was dilated, the spermatids and spermatocytes were more generally depleted. After 5 weeks of age, spermatogenic defects were no more observed and the NRTN overexpressing mice were fertile. The data suggest that NRTN might regulate survival and differentiation of spermatocytes and spermatids, but the low penetrance indicates that either the transgene expression has not been high enough or NRTN is not as essential as GDNF for spermatogenesis.


Subject(s)
Drosophila Proteins , Nerve Growth Factors/pharmacology , Spermatogenesis/drug effects , Testis/drug effects , Animals , Gene Expression Regulation , Glial Cell Line-Derived Neurotrophic Factor Receptors , Humans , Male , Mice , Mice, Transgenic , Nerve Growth Factors/genetics , Nerve Growth Factors/metabolism , Neurturin , Phenotype , Promoter Regions, Genetic , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-ret , RNA, Messenger/metabolism , Receptor Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases/metabolism , Spermatogenesis/genetics , Spermatogonia/cytology , Spermatogonia/drug effects , Testis/cytology , Testis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...